Leveraging Evolving Data to Inform Treatment in HR-Positive, HER2-Negative Advanced Breast Cancer

Watch the interactive on-demand Webcast and download the slides from a CCO symposium at SABCS 2019 to get up to date on the latest clinical data informing optimal treatment of HR+/HER2- MBC including expert discussion of patient cases and  a look ahead at promising agents in the setting of endocrine therapy&ndash pretreated disease that may soon change practice.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

Supported by educational grants from

Immunomedics

Lilly